Skip to menu Skip to content Skip to footer

2022

Book Chapter

Solutions

Htay, Htay, Johnson, David W., Strippoli, Giovanni F. M., Craig, Jonathan C. and Cho, Yeoungjee (2022). Solutions. Evidence-based nephrology. (pp. 127-137) edited by Jonathan C. Craig, Donald A. Molony and Giovanni F. M. Strippoli. Hoboken, NJ USA: John Wiley & Sons. doi: 10.1002/9781119105954.ch47

Solutions

2022

Book Chapter

Peritoneal dialysis: infections

Nguyen, Thu T., Palmer, Suetonia C., Cho, Yeoungjee, Mudge, David W., Strippoli, Giovanni F. M., Craig, Jonathan C., Johnson, David W. and Htay, Htay (2022). Peritoneal dialysis: infections. Evidence-based nephrology. (pp. 138-155) edited by Jonathan C. Craig, Donald A. Molony and Giovanni F. M. Strippoli. Hoboken, NJ USA: John Wiley & Sons. doi: 10.1002/9781119105954.ch48

Peritoneal dialysis: infections

2022

Book Chapter

Peritoneal dialysis solutions

Ambarsari, Cahyani Gita, Cho, Yeoungjee and Johnson, David W. (2022). Peritoneal dialysis solutions. Handbook of dialysis therapy. (pp. 222-229) edited by Allen R. Nissenson, Richard N. Fine, Rajnish Mehrotra and Joshua Zaritsky. Amsterdam, Netherlands: Elsevier. doi: 10.1016/B978-0-323-79135-9.00022-7

Peritoneal dialysis solutions

2022

Book Chapter

Urgent-start peritoneal dialysis

Stallard, Belinda, Johnson, David W., Htay, Htay, Strippoli, Giovanni F. M., Craig, Jonathan C. and Cho, Yeoungjee (2022). Urgent-start peritoneal dialysis. Evidence-based nephrology. (pp. 156-169) edited by Jonathan C. Craig, Donald A. Molony and Giovanni F.M. Strippoli. Chichester, West Sussex, United Kingdom: Wiley. doi: 10.1002/9781119105954.ch49

Urgent-start peritoneal dialysis

2016

Book Chapter

Aminoglycoside use in patients with chronic kidney disease

Nataatmadja, Melissa, Cho, Yeoungjee, Lloyd, Jess and Johnson, David W. (2016). Aminoglycoside use in patients with chronic kidney disease. Aminoglycosides: pharmacology, clinical uses and health effects. (pp. 53-76) edited by Ruthie Alves. New York, NY, United States: Nova Science Publishers.

Aminoglycoside use in patients with chronic kidney disease